Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Global retrospective analysis of clinician- and patient-reported clinical characteristics and humanistic burden of patients with gastroesophageal cancers on first-line treatment

Fig. 1

EQ-5D-3L utility index scores for patients with GC/GEJC/EAC, HER2 status negative/unknown, on first-line treatment. EAC, esophageal adenocarcinoma; EQ-5D-3L, EuroQol 5-Dimension 3-Level Questionnaire; GC, gastric cancer; GEJC, gastroesophageal junction cancer; UK, United Kingdom; US, United States

Back to article page